ID   GZHMCi007-A
AC   CVCL_A7GC
DR   hPSCreg; GZHMCi007-A
DR   Wikidata; Q107115212
RX   PubMed=34403853;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18078; ZBTB7A.
CC   Sequence variation: Mutation; HGNC; HGNC:4824; HBA2; Simple; p.Ter143Glnext*32 (c.427T>C); ClinVar=VCV000015624; Zygosity=Homozygous; Note=Hb Constant Spring (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34403853
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 19,21
ST   D13S317: 8,10
ST   D16S539: 11
ST   D18S51: 11,14
ST   D19S433: 12,15.2
ST   D1S1656: 15,16
ST   D21S11: 29,32.2
ST   D2S1338: 23
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D6S1043: 10,12
ST   D7S820: 11,12
ST   D8S1179: 10,12
ST   FGA: 24
ST   Penta D: 9
ST   Penta E: 10,15
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C34368; Alpha thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4G8 ! SU-iPS-1
SX   Male
AG   6M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
RX   PubMed=34403853; DOI=10.1016/j.scr.2021.102494;
RA   Chen D.-Y., Song B., Cheng Y., Zhu L.-F., Lu D., Liu N.-Q., Yang Y.-H.,
RA   Sun X.-F.;
RT   "Generation of a homozygous ZBTB7A knockout human induced pluripotent
RT   stem line by CRISPR/Cas9 editing.";
RL   Stem Cell Res. 55:102494-102494(2021).
//